A case report of crystalline light chain inclusion-associated kidney disease affecting podocytes but without Fanconi syndrome: A clonal analysis of pathological monoclonal light chain.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
Feb 2019
Historique:
entrez: 1 2 2019
pubmed: 1 2 2019
medline: 27 2 2019
Statut: ppublish

Résumé

Crystalline light chain inclusion-associated kidney disease affects mainly tubular epithelial cells and is often clinically manifested as Fanconi syndrome. However, only very few case reports about the crystalline deposits within the podocytes are available, and the nature of the pathogenic monoclonal light chain implicated in these cases is still unknown. We report a case of crystalline inclusion-associated kidney disease manifested as crystalline podocytopathy in which we identified the complete structure of the pathogenic monoclonal light chain as belonging to the germ-line gene of Vκ1-39. We describe a 65-year-old woman with crystalline light chain inclusion-associated kidney disease showing mild proteinuria and renal insufficiency with monoclonal gammopathy of undetermined significance without Fanconi syndrome. She had crystalline inclusions mainly within podocytes, tubular epithelial cells and histiocytes in the kidney. Light microscopy showed vacuolation of podocytes and tubular epithelial cells, while eosin negative pale needle-like crystals were present within these cells. Electron microscopy showed accumulation of club-like crystals with high electron density in podocytes, proximal tubular epithelial cells and interstitial histiocytes. Clonal analysis revealed that a pathogenic monoclonal light chain was derived from germline gene, Vκ1-39. The diagnosis of crystalline light chain inclusion-associated kidney disease was made. Bortezomib and dexamethasone were started and her renal function improved to eGFR 36 mL/min/1.73 m after 9 courses of therapy. Patients with light chain crystalline podocytopathy may have a similar pathogenic monoclonal light chain derived from the same germline gene, Vκ1-39, to that of patients with light chain proximal tubulopathy.

Identifiants

pubmed: 30702553
doi: 10.1097/MD.0000000000013915
pii: 00005792-201902010-00002
pmc: PMC6380839
doi:

Substances chimiques

Immunoglobulin Light Chains 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13915

Références

Hum Pathol. 1999 Dec;30(12):1441-8
pubmed: 10667422
J Immunol. 1995 Sep 15;155(6):3245-52
pubmed: 7673737
Clin Nephrol. 2004 Sep;62(3):229-33
pubmed: 15481856
Nephrology (Carlton). 2005 Feb;10(1):81-3
pubmed: 15705186
Blood. 2002 Sep 1;100(5):1817-27
pubmed: 12176905
Hum Pathol. 2014 Apr;45(4):875-9
pubmed: 24439928
J Immunol. 1982 Nov;129(5):2016-20
pubmed: 6811655
Am J Kidney Dis. 1994 Jun;23(6):859-65
pubmed: 8203369
J Am Soc Nephrol. 2016 May;27(5):1555-65
pubmed: 26374607
Arch Pathol Lab Med. 1991 Apr;115(4):351-4
pubmed: 2012495
Blood. 1999 Nov 15;94(10):3559-66
pubmed: 10552967
Intern Med. 2016;55(4):369-73
pubmed: 26875962
Am J Kidney Dis. 2010 Jun;55(6):1136-41
pubmed: 19850387
J Clin Invest. 1997 Apr 1;99(7):1614-27
pubmed: 9120005
Am J Kidney Dis. 2003 Sep;42(3):605-11
pubmed: 12955694
Kidney Int. 2006 Feb;69(3):616-20
pubmed: 16514437
Am J Kidney Dis. 1989 Jul;14(1):56-60
pubmed: 2545097
Virchows Arch. 2004 Jul;445(1):83-9
pubmed: 15278450
Kidney Int. 2011 Jun;79(12):1289-301
pubmed: 21490587
J Immunol. 1993 Apr 15;150(8 Pt 1):3561-8
pubmed: 8468490
Mod Rheumatol. 2016 Nov;26(6):923-928
pubmed: 26943245
Kidney Int. 2015 Apr;87(4):698-711
pubmed: 25607108
Protein Eng. 1999 Apr;12(4):363-9
pubmed: 10325408

Auteurs

Kiyoaki Ito (K)

Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa.

Satoshi Hara (S)

Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa.

Kazunori Yamada (K)

Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa.

Takeshi Zoshima (T)

Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa.

Ichiro Mizushima (I)

Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa.

Hiroshi Fujii (H)

Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa.

Ryoichi Miyazaki (R)

Department of Internal Medicine, Fujita Memorial Hospital.

Yasukazu Kawai (Y)

Department of Hematology and Oncology, Fukui Prefectural Hospital, Fukui.

Akihiro Yachie (A)

Department of Pediatrics, Kanazawa University Graduate School of Medicine, Kanazawa.

Michio Nagata (M)

Department of Kidney and Vascular Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Shozo Izui (S)

Department of Pathology and Immunology, University Medical Center, University of Geneva, Switzerland.

Masakazu Yamagishi (M)

Division of Cardiology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.

Mitsuhiro Kawano (M)

Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH